---
title: "Chase Sun Pharmaceuticals released its performance for the first half of the year, with a net profit attributable to the parent company of 78.63 million yuan, a decrease of 46.95%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/254756264.md"
description: "According to the Zhitong Finance APP, Chase Sun released its semi-annual report for 2025, showing an operating income of 2.795 billion yuan, a year-on-year decrease of 6.72%. The net profit attributable to shareholders of the listed company was 78.63 million yuan, a year-on-year decrease of 46.95%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 69.1796 million yuan, a year-on-year decrease of 49.53%. The basic earnings per share were 0.03 yuan"
datetime: "2025-08-27T08:09:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254756264.md)
  - [en](https://longbridge.com/en/news/254756264.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254756264.md)
---

# Chase Sun Pharmaceuticals released its performance for the first half of the year, with a net profit attributable to the parent company of 78.63 million yuan, a decrease of 46.95%

According to the Zhitong Finance APP, Chase Sun (300026.SZ) released its semi-annual report for 2025, showing an operating income of 2.795 billion yuan, a year-on-year decrease of 6.72%. The net profit attributable to shareholders of the listed company was 78.63 million yuan, a year-on-year decrease of 46.95%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 69.1796 million yuan, a year-on-year decrease of 49.53%. The basic earnings per share were 0.03 yuan

### Related Stocks

- [300026.CN](https://longbridge.com/en/quote/300026.CN.md)

## Related News & Research

- [EU wheat rises with Black Sea disruption in focus](https://longbridge.com/en/news/294993441.md)
- [Hard Red Spring Wheat Price Trends: 50 & 200-Month Moving Averages](https://longbridge.com/en/news/294861562.md)
- [Marvel Biosciences says MB-204 reverses cognitive, behavioral deficits in Fragile X mouse study](https://longbridge.com/en/news/294936790.md)
- [PIDILITIND: Strong revenue and profit growth, aided by exceptional gains and broad segment expansion](https://longbridge.com/en/news/294796600.md)
- [Chip foundry warns 2027 wafer price hikes will be steeper as Singapore fab sells out](https://longbridge.com/en/news/294887505.md)